Felicia Qashu
Affiliations: | Neuroscience | USU, Logan, UT, United States |
Google:
"Felicia Qashu"Mean distance: 17.6 (cluster 6) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, et al. (2013) Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration. The Journal of Pharmacology and Experimental Therapeutics. 344: 133-40 |
| Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, et al. (2011) Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. British Journal of Pharmacology. 164: 1495-505 |
| Williams LR, Aroniadou-Anderjaska V, Qashu F, et al. (2011) RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environmental Health Perspectives. 119: 357-63 |
| Figueiredo TH, Qashu F, Apland JP, et al. (2011) The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. The Journal of Pharmacology and Experimental Therapeutics. 336: 303-12 |
| Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, et al. (2011) Efficacy of Topiramate Against Soman Intoxication: Attenuation of Seizures Without Neuroprotection American Journal of Neuroprotection and Neuroregeneration. 3: 59-65 |
| Apland JP, Figueiredo TH, Qashu F, et al. (2010) Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology. Neurotoxicology. 31: 485-92 |
| Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, et al. (2010) Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis. Amino Acids. 38: 189-97 |
| Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, et al. (2009) Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology. 30: 772-6 |
| Fritsch B, Qashu F, Figueiredo TH, et al. (2009) Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience. 163: 415-29 |
| Aroniadou-Anderjaska V, Fritsch B, Qashu F, et al. (2008) Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Research. 78: 102-16 |